Anti-XIAP antibody [EPR22189-113]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(12 Publications)
Rabbit Recombinant Monoclonal XIAP antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 12 publications.
View Alternative Names
API3, BIRC4, IAP3, XIAP, E3 ubiquitin-protein ligase XIAP, Baculoviral IAP repeat-containing protein 4, IAP-like protein, Inhibitor of apoptosis protein 3, RING-type E3 ubiquitin transferase XIAP, X-linked inhibitor of apoptosis protein, ILP, hILP, IAP-3, hIAP-3, hIAP3, X-linked IAP
- WB
Supplier Data
Western blot - Anti-XIAP antibody [EPR22189-113] (AB229050)
Blocking/Dilution buffer : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 25535897).
All lanes:
Western blot - Anti-XIAP antibody [EPR22189-113] (ab229050) at 1/1000 dilution
Lane 1:
HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg
Lane 2:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 3:
WI-38 (human fetal lung fibroblast cell line) whole cell lysate at 20 µg
Lane 4:
HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Lane 5:
A549 (human lung carcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 57 kDa
Observed band size: 50-56 kDa
false
Exposure time: 37s
- WB
Lab
Western blot - Anti-XIAP antibody [EPR22189-113] (AB229050)
False colour image of Western blot : Anti-XIAP antibody [EPR22189-113] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab229050 was shown to bind specifically to XIAP. A band was observed at 60 kDa in wild-type A549 cell lysates with no signal observed at this size in XIAP knockout cell line ab289043. To generate this image, wild-type and XIAP knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-XIAP antibody [EPR22189-113] (ab229050) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
XIAP knockout A549 cell lysate at 20 µg
Lane 3:
MCF7 cell lysate at 20 µg
Lane 4:
MOLT-4 cell lysate at 20 µg
Observed band size: 60 kDa
false
- WB
Supplier Data
Western blot - Anti-XIAP antibody [EPR22189-113] (AB229050)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-XIAP antibody [EPR22189-113] (ab229050) at 1/1000 dilution
Lane 1:
C6 (rat glial tumor cell line) whole cell lysate at 10 µg
Lane 2:
RAW 264.7 (mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 3:
PC-12 (rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 4:
NIH/3T3 (mouse embryo fibroblast cell line) whole cell lysate at 10 µg
Lane 5:
Neuro-2a (mouse neuroblastoma cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 57 kDa
Observed band size: 50-56 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-XIAP antibody [EPR22189-113] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of XIAP involves regulation of apoptosis an important process in maintaining cellular homeostasis. It forms part of the apoptosome complex by interacting with caspases to prevent premature cell death. XIAP serves to protect cells from stress-induced apoptotic signals helping in survival under adverse conditions. This ability makes it a subject of interest in studying cancer survival mechanisms since overactive XIAP can allow cancer cells to avoid programmed cell death.
Pathways
Apoptosis regulation and cell survival pathways prominently feature XIAP. Particularly XIAP plays a role in the intrinsic apoptotic pathway which is activated in response to internal stress signals. XIAP regulates this pathway via its interaction with caspase-9 and interactions with other proteins such as Smac/DIABLO which can antagonize XIAP's function. This interaction is key in balancing cell death and survival therefore highlighting its role in apoptosis control.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular medicine 55: PubMed39670303
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neuroreport 34:685-692 PubMed37556588
2023
Applications
Unspecified application
Species
Unspecified reactive species
BMC musculoskeletal disorders 23:789 PubMed35978328
2022
Applications
Unspecified application
Species
Unspecified reactive species
BioMed research international 2022:1327835 PubMed35572727
2022
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 20:101356 PubMed35339891
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasma 69:370-382 PubMed35081724
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of nanomedicine 16:6329-6343 PubMed34556984
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of geriatric cardiology : JGC 18:426-439 PubMed34220972
2021
Applications
Unspecified application
Species
Unspecified reactive species
Annals of clinical and laboratory science 51:231-240 PubMed33941563
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:661 PubMed33968191
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com